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I. Introduction 
Prostaglandin PGEl increases sodium and water 
transport across the isolated toad bladder [ 1, 21. It in- 
hibits the water permeabiIity response to both vaso- 
pressin and theophylline but does not affect the re- 
ponse to exogenous cyclic AMP [2, 31. In renal col- 
lecting tubules, Grantham and Orloff [4] have report- 
ed a slight increase in water permeability following 
prostaglandin PGEl treatment, but an inhibition of 
the vasopressin-stimulated response. They proposed 
that both vasopressin and prostaglandin PGEl act on 
a common receptor. An alternative explanation by 
Orloff and Handler [ 51 suggests that two cell types 
exist in kidney tubules, which are separately stimu- 
lated or inhibited by prostaglandin PGEl. 
Measurements of the effects of vasopressin and 
prostaglandin PGEl on adenylate cyclase activity in 
toad bladder [l] and hamster kidney [6] have been 
somewhat inconclusive and the differential effects of 
prostaglandin PGEl on vasopressin-stimulated Na’ and 
water transport have been considered to involve two 
adenylate cyclase systems in the toad bladder. 
In the present work we have studied the dose re- 
sponse characteristic for vasopressin-stimulated cyclic 
AMP concentration in toad bladder and the effect of 
certain prostaglandins on the concentration of cyclic 
AMP stimulated by vasopressin and theophylline in 
rat kidney and toad bladder. 
2. Materials and methods 
Vasopressin (&arginine) was obtained as pitressin 
(Parke Davis Co. Ltd.), the prostaglandins were gener- 
North-Holland Acblishing Company - Amsterdam 
ously supplied by Dr. J.E. Pike (Upjohn Co. Ltd.) and 
[3H]cyclic AMP (specific activity 6.5 Ci/mmole) was 
obtained from the Radiochemical Centre, Amersham. 
Frog Ringer’s solution contained Na’ 113.5 mequiv./Q, 
K’ 3.5 mequiv./Q, Cl- 116.5 mequiv./Q, HCO; 2.4 
mequiv./Q and Ca*+ 0.89 mM. Robinson’s kidney slice 
medium was prepared as described [7]. 
2.1. Vasopressin-stimulated cyclic AMP concentrations 
in toad bladder 
All toads (Bufo marinus) were rapidly pithed and 
the half bladders promptly exsanguished, excised and 
weighed. They were incubated for 90 min at 22”, in 
aerated frog Ringer (10 ml) and then for a further 20 
min as matched pairs in the presence of a given dose 
of pitressin or under control conditions. The tissue 
was homogenised in ice-cold 5.6% w/v trichloroacetic 
acid (4 ml) containing a trace of [3H]cyclic AMP as 
an internal standard. The TCA was extracted into 
water-saturated iethyl ether (3 X 40 ml) and the 
aqueous layer collected and fractionated for cyclic 
AMP using a slightly modified method (Krishna et al. 
[8]). The cyclic AMP fraction was lyophilised and as- 
sayed in triplicate using the technique described by 
Brooker et al. [9]. The recovery of cyclic AMP was 
approx. 60%. 
2.2. Time course experiments 
Bladders excised and preincubated as previously 
described were incubated over a 20 min period in the 
presence of vasopressin (100 mu/ml) or vasopressin 
(2 mu/ml) plus theophylline (1 mM). The rate of in. 
crease in cyclic AMP concentration was measured by 
269 
Volume 31, number 3 FEBS LETTERS May 1973 
removing bladder sections every 5 min during the in- 
cubation period for cyclic AMP assay. 
2.3. Effect of prostaglandins 
We have measured the effect of various concentra- 
tions of PGEl (IO-‘- l(r’ M) on the cyclic AMP con- 
centration, stimulated during a 20 min incubation by 
100 mu/ml vasopressin and 2 mu/ml vasopressin plus 
1 mM theophylline in hypo- (10 X dilution) and iso- 
tonic conditions. 
A corresponding set of experiments has examined 
the effect of 1.4 X 1 V7 M prostaglandin PGF la on 
the cyclic AMP levels stimulated in the presence of 
1 mM theophylline by vasopressin (2 mu/ml and 100 
mu/ml). In these experiments the bladder sections 
were excised, preincubated and cyclic AMP assayed 
as previously described. Each experiment has been 
repeated 2-3 times. 
2.4, Rat kidney experiments 
Male Wistar rats (150 g) were killed and the kidneys 
sliced using a Staddie Riggs microtome. The slices were 
incubated for 15 min at 30” in aerated Robinson’s kid- 
ney slice medium (10 ml). The effect of prostaglandins 
on the vasopressin (2 mu/ml) plus theophylline (1 mM) 
stimulated cyclic AMP concentrations in kidney slices 
was studied by incubating rat kidney slices in the ab- 
sence and presence of l(r’ M prostaglandins PGAz , 
PGEz or PGE2&. In these experiments the cyclic AMP 
concentration was determined per mg wet weight and 
per mg protein, using Brown et al. [IO] protein bind- 
ing assay after extraction of cyclic AMP with perchloric 
acid. 
3. Results 
The vasopressin-stimulated cyclic AMP concentra- 
tion in toad bladder (fig. 1) has a dose response charac- 
teristic of a single activation process. The dose required 
to give a half maximum response suggests a K,, value 
for hormone-receptor binding of the order lo8 Q/mole 
(450 U = 1 mg vasopressin) assuming that the increased 
concentration of cyclic AMP occurs as a direct effect 
of hormone interaction. The time course for vasopressin- 
stimulated cyclic AMP production in toad bladder shows 
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Fig. 1. Increased concentration of cyclic AMP in toad bladders, 
stimulated by various doses of vasopressin. Expressed as a per- 
centage increase above the matched pair control. Each point 
represents the mean of three values. Mean value for the concen- 
tration of cyclic AMP in control tissue 2.13 pmole/mg wet wt. 
Fig. 2. Rate of increase of cyclic AMP concentration in toad 
bladder stimulated by 100 mU/ml vasopressin. Expressed as 
a percentage increase above the control (single expt.). Value 
for the concentration of cyclic AMP in control tissue 0.72 
pmole/mg wet wt. 
(fig. 2) a steady increase, reaching a maximum 10 min 
after addition of the hormone, following which cyclic 
AMP concentration in the tissue falls. In the presence 
of 1 mM theophylline the cyclic AMP concentration 
rises steadily over the 20 min period. 
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Fig. 3. Increased concentration of cyclic AMP in toad bladder 
stimulated by various doses of prostaglandin PGEr in isotonic 
conditions, in the presence of 100 mu/ml vasopressin (mean 
of 2 expts., a--a---a), or of 2 mu/ml vasopressin plus 1(r3 
M theophylline (mean of 2 expts., o-o-o) and in hypo- 
tonic conditions 2 mu/ml vasopressin plus 1r3 M theophylline 
(mean of 3 expts., n---o---o). Mean value for the concentra- 
tion of cyclic AMP in control tissues 1.48, 1.48, 1.39 pmoles/ 
mg wet wt., respectively. 
Studies of the effect of prostaglandin PGEt on the 
vasopressin plus theophylline stimulated cyclic AMP 
concentrations have shown (fig. 3) a potentiation ef- 
fect at concentrations in the range 1 Cr9 - 1 CJ7 M. This 
effect of prostaglandin PGEr is observed in both hypo- 
and isotonic conditions, a result contrary to that ex- 
pected on the basis of its inhibitory effect on vasopres- 
sin and theophylline-stimulated water transport. In the 
presence of higher doses of vasopressin (100 mu/ml), 
Table 1 
The effects of prostaglandin PGFro on toad bladder cyclic 
AMP levels in the presence of 1 mM theophylline. 
cyclic AMP 
(pmoles/mg wet wt.) 
Vasopressin (2 mu/ml) 
Vasopressin. (2 mu/ml) 
+ PGFr, (10-7 hl) 
Vasopressin (100 mu/ml) 
Vasopressin (100 mu/ml) 
+ PGFr, (1r7 M) 
1.96 
4.60 
5.40 
6.60 
Table 2 
Effect of prostaglandin Aa on rat kidney cyclic AMP concen- 
tration. 
cyclic AMP 
Control 
Vasopressin (2 mu/ml) 
Vasopressin + PGA2 
PGA2 (1.4 x 1r7 M) 
(pmoleslmg (pmoles/mg 
wet wt., protein, 
mean + S.E.M.) mean f S.E.M.) 
1.60 * 0.08 14.04 * 1.31 
2.59 * 0.07 23.74 * 0.92 
2.25 f 0.09 20.17 5 0.20 
2.27” 0.10 21.09 + 0.78 
Table 3 
Comparison of the effects of prostaglandins E2, Aa and Fao, 
on cyclic AMP concentrations in rat kidney in the presence of 
1r3 M theophylline. 
cyclic AMP (pmoles/mg protein) 
PGA2 PGE2 PGFzcx 
Control 14.0 17.6 17.6 
Vasopressin (2 mu/ml) 23.7 30.4 30.4 
Vasopressin + PG 20.2 27.2 24.6 
PG (1.4 x 1f17 M) 21.1 38.2 37.3 
The results are presented as the mean of 3-5 values. 
the concentration of cyclic AMP in the tissue may be 
expected to be maximal and in these conditions pros- 
taglandin PGEr has a more limited effect. A similar 
potentiation of the vasopressin plus theophylline stim- 
ulated cyclic AMP concentration has been observed, 
using prostaglandin PGFr, (table l), which again shows 
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a more limited effect in the presence of higher doses of 
vasopressin. 
The effects of the renal prostaglandins PGAz , PGEa 
and PGFI, on cyclic AMP concentrations in rat kidney 
(tables 2 and 3) have shown that each has a stimulatory 
effect on basal cyclic AMP concentrations in the pre- 
sence of 1 mM theophylline but an inhibitory effect 
on the vasopressin plus theophylline-stimulated con- 
centrations. 
4. Discussion 
The dose response characteristic for vasopressin- 
stimulated cyclic AMP concentrations in toad bladder 
indicates a single adenylate cyclase sensitive to the 
hormone. The high level of hormone required to stim- 
ulate cyclic AMP maximally may not be related to the 
dose of hormone required for maximum stimulation 
of sodium transport [ 111, a finding that again raises 
the question of the role of increased cyclic AMP con- 
centrations in the control of sodium permeability of 
the toad bladder. 
In characterising the mechanism of action of octa- 
peptide hormones on ion and water transport across 
the isolated toad bladder and frog skin [ 11, 121, a 
distinction has been made between cyclic AMP medi- 
ated effects that predominantly affect water perme- 
ability and a direct permeability effect of the hormone 
[ 131 that is believed to primarily affect Na’ transport. 
There is a considerable amount of evidence supporting 
a separation of water and Na+ transport effects of vaso- 
pressin [ 14-161 and it may be concluded that an im- 
portant part of vasopressin action may not be related 
to the stimulated cyclic AMP concentration. 
The dose response characteristics obtained for pros- 
taglandin PGEr stimulation of cyclic AMP concentra- 
tions in the presence of vasopressin and theophylline 
have similar half maxima under different conditions. 
This result is taken to indicate a separate and specific 
high affinity binding site for the prostaglandin. The 
limited effect of prostaglandins PGEr and PGFr, in 
the presence of high doses of hormone suggests an ef- 
fect associated with a single adenylate cyclase that is 
maximally stimulated in the presence of hormone and 
prostaglandin. 
The prostaglandin inhibition of vasopressin-stimu- 
lated water transport across the isolated toad bladder 
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does not appear to involve a physiological effect on 
cyclic AMP concentrations. It was possible that pre- 
vious studies on the effect of prostaglandins on toad 
bladder adenylate cyclase preparations might have 
failed to reveal any indirect effects of the prostaglan- 
dins. However, the present work indicates that the in- 
hibitory effects of prostaglandin on the vasopressin- 
stimulated water transport is probably independent 
of any effect on cyclic AMP levels. A similar result 
has been found for 10 mM Ca” which inhibits the 
vasopressin water transport response but has no ef- 
fect on cyclic AMP levels in toad bladder [ 171. 
There is some evidence of an inhibitory effect of 
the prostaglandins PGEz , PGFs, and PGAa on renal 
cyclic AMP concentrations. This result agrees with an 
earlier report by Beck et al. [ 181, who obtained inhib- 
itory effects of prostaglandin PGEr in renal medullary 
tissue, and suggests that a prostaglandin or similar sub- 
stance may act in the kidney to regulate vasopressin 
action. 
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